Switzerland· 68388002
Trixeo Aerosphere 5/7.2/160 μg, Druckgasinhalation, Suspension
A formoterol, glycopyrronium bromid und budesonid product containing budesonidum, glycopyrronium, formoteroli fumaras dihydricus, registered in Switzerland by AstraZeneca AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Formoterol, glycopyrronium bromid und budesonid is registered in 11 of 19 countries.
Countries holding a registration under ATC R03AL11 (formoterol, glycopyrronium bromid und budesonid), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Formoterol, glycopyrronium bromid und budesonid · ATC R03AL11
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- budesonidum, glycopyrronium, formoteroli fumaras dihydricus
- Manufacturer
- AstraZeneca AG
- Country
- Switzerland (CH)
- ATC code
- R03AL11
- ATC class
- Formoterol, Glycopyrronium bromid und Budesonid
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680683880026120 DosCHF 74.15
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Formoterol, glycopyrronium bromid und budesonid in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IcelandRiltrava AerosphereAstraZeneca AB
- NetherlandsRiltrava Aerosphere 5 microgram/7,2 microgram/160 microgram, aerosol, suspensie, suspensieAstraZeneca AB
- PolandRiltrava AerosphereAstraZeneca AB
- CanadaBREZTRI AEROSPHEREASTRAZENECA CANADA INC
- SpainTRIXEO AEROSPHERE 5 microgramos/7,2 microgramos/160 microgramos SUSPENSION PARA INHALACION EN ENVASE A PRESIONAstrazeneca Ab
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c301590b-054b-45db-9d8b-e2fdd8739439 GET /v1/drugs/c301590b-054b-45db-9d8b-e2fdd8739439?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "formoteroli fumaras dihydricus 5 mcg + glycopyrronium 7.2 mcg + budesonidum 160 mcg",
"valid_from": "2022-06-01",
"limitations": "[{\"description\":\"Für Patienten mit moderater COPD nach ≥ 1 moderaten Exazerbation pro Jahr trotz einer mindestens 3 Monate dauernder optimierter Therapie unter LABA/LAMA mit Eosinophilenzellzahl im Blut ≥ 100 Zellen/μl, welche nicht ausreichend eingestellt sind<br>\\noder<br>\\nfür Patienten mit moderater bis schwerer COPD nach ≥ 2 moderaten Exazerbationen pro Jahr oder ≥ 1 Exazerbation pro Jahr, welche zu einer Hospitalisation geführt hat trotz einer mindestens 3 Monaten dauernden optimierter Therapie unter ICS/LABA oder LABA/LAMA (für LABA/LAMA mit Eosinophilenzellzahl im Blut ≥ 100 Zellen/μl), welche nicht ausreichend eingestellt sind<br>\\noder<br>\\nfür Patienten mit COPD, welche bereits mit einer Dreifach-Kombination bestehend aus LABA, ICS und LAMA mit einem oder mehreren Inhalatoren therapiert werden.<br>\\n<br>\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2022-06-01\"}]",
"galenic_form": "Inhalator 5/7.2/160 mcg",
"therapeutic_area": null,
"sl_inclusion_date": "2022-06-01",
"self_retention_pct": 10
}See everything about formoterol, glycopyrronium bromid und budesonid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.